Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platform.

Clin Transl Immunology · 2021 · PMC7853904 · PMID 33552509

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

could be considered significantno p-value reported

Paired or unpaired Student's t ‐tests were applied to determine whether the differences between groups could be considered significant.

also in 229 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.